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Objective: The aim of this study was to identify any potential genetic overlap between
attention deficit hyperactivity disorder (ADHD) and obsessive compulsive disorder
(OCD). We hypothesized that since these disorders share a sub-phenotype, they may
share common risk alleles. In this manuscript, we report the overlap found between
these two disorders.
Methods: A meta-analysis was conducted between ADHD and OCD, and polygenic risk
scores (PRS) were calculated for both disorders. In addition, a protein-protein analysis
was completed in order to examine the interactions between proteins; p-values for the
protein-protein interaction analysis was calculated using permutation.
Conclusion: None of the single nucleotide polymorphisms (SNPs) reached genome
wide significance and there was little evidence of genetic overlap between ADHD and
OCD.
Keywords: ADHD, OCD, GWAS, meta-analysis, polygenic score, protein-protein link analysis, eQTL
INTRODUCTION
Attention deficit hyperactivity disorder (ADHD) and obsessive compulsive disorder (OCD)
are two neurodevelopmental disorders with their onset in childhood. They are two of the
most common psychiatric disorders found in pediatric populations. Approximately 5% of
the population worldwide has ADHD (Simon et al., 2009). ADHD is most often characterized
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by inattention, hyperactivity and impulsivity and affects twice as
many males compared to females (Polanczyk et al., 2007). OCD
is characterized by recurring obsessions and/or compulsions.
Obsessions are unwanted thoughts, ideas and impulses that occur
more than once, while compulsions are repetitive behaviors that
are driven by the obsessions (American Psychiatric Association,
2016). OCD affects up to 2% of the world’s population and is
4.5 times more common in males than females (Eaton et al.,
2008).
The comorbidity of ADHD and OCD was found to range
vastly from 10% to 50% (Geller et al., 1996;Masi et al., 2006; Brem
et al., 2014; Abramovitch et al., 2015). Some studies may have
exhibited high comorbidity rates because ADHD often presents
with inattention and distractibility, which could be misdiagnosed
as OCD (Geller et al., 2002). This shared clinical feature of the
disorders often makes diagnosis difficult. Geller et al. (2002)
indicated that the ADHD symptoms found in OCD patients are
not sub-symptoms of OCD, but instead true comorbidity of the
disorders.
Several studies have been conducted that to examine
the overlapping sub-phenotypes between ADHD and OCD.
Sheppard et al. (2010) documented that ADHD and OCD share
symptoms of inattention and distraction and co-segregation in
families. Recently, Park et al. (2016) pointed out that hoarding; a
common symptom observed in OCD, may be linked to executive
functioning deficits were found to be associated with ADHD
(Park et al., 2016). Additionally, individuals with ADHD and
OCD are thought to share diminished inhibitory control, which
is conveyed through impulsivity in ADHD, and poor control of
obsessions and compulsions in OCD (Norman et al., 2016). The
recent evidence of these overlapping symptoms between ADHD
and OCD serve as the motivation for this study. Because the
clinical relationship has been well established in the literature
(Geller et al., 1996; Masi et al., 2006), we sought to examine the
genetic relationship between ADHD and OCD.
There have been studies for assessing potential genetic
overlap between two neurological disorders using genome wide
association study (GWAS) data. Davis et al. (2013) conducted an
analysis between Tourette’s Syndrome (TS) and OCD, utilizing a
similar approach to our study. Davis et al. (2013) found overlap
between the two disorders with a genetic correlation of 0.41
(p-value < 0.002). This also justified our efforts to conduct an
analysis between ADHD and OCD, which to our knowledge had
not been previously studied, as the Davis et al. (2013) study used
statistical tests that yielded significant results for a genetic link
between TS and OCD.
To achieve our research goal, we performed a meta-analysis
between the ADHD (N = 3351) and OCD (N = 5415) samples.
The ADHD sample contained 2064 trios, 896 cases, and
2455 controls. The OCD sample consisted of 2998 individuals
from nuclear families. Further, the meta-analysis results are
examined for the enrichment of functional single nucleotide
polymorphisms (SNPs) that were previously associated with
gene expression levels. Additionally, polygenic risk score (PRS)
analyses were completed to test the hypothesis that multiple
genes of small effect jointly contribute to the susceptibility
of ADHD and OCD. PRS analyses were also conducted
to investigate the genetic relationship between these two
disorders. Furthermore, an additional analysis was conducted
to examine protein-protein interactions to examine potential
common pathways between proteins. Lastly, an expression
quantitative trait locus (eQTL) analysis was carried out to identify
non-randomly occurring genes that are associated with the
prefrontal cortex region.We used the nominated genes generated
by two additional approaches: eQTL and Disease Association
Protein-Protein Link Evaluator (DAPPLE)1, to explore the
potential overlap between the two lists (Rossin et al., 2011).
MATERIALS AND METHODS
Samples
OCD Data
The OCD data includes a total of 2998 individuals. This
sample consists of 1406 patients that come from 1065 European
families. Six-hundred and twenty-one families were recruited
at one of the five recruitment sites and the National Institute
of Mental Health. Four-hundred and forty-four families were
previously evaluated for an earlier study at Johns Hopkins
University; one of our collaborating sites. The final sample is
made up of 460 complete trios (an affected proband and both
parents), 155 pedigrees (a proband and unaffected sibling), and
450 families with a complex family structure. An additional
192 probands that lacked another family member in the study
(singletons) were included in the sample as well. The genotyping
was performed at the JohnsHopkins SNPCenter using Illumina’s
HumanOmniExpress bead chips.
GENEVA Controls
The Gene Environment Association Studies (GENEVA) seek to
identify genetic factors that may play a part in addiction, in the
form of a large genome-wide association study. The subjects are
DSM-IV alcohol dependent as well as illicit drug dependent cases
and controls. The controls are non-dependent and unrelated
subjects of European and African American descent. This data is
available for download at the dbGaP database (phs000092.v1.p1).
One-thousand-two-hundred and ninty-six of the European
controls were combined with the OCD data for PRS analyses, as
there were very few controls in the OCD data. The samples were
genotyped using the Illumina Human 1M platform.
ADHD Data
The ADHD dataset was downloaded from the Psychiatric
Genomics Consortium (PGC)2. This data contains only the
summary statistics; no individual level data was included. This
data combined four projects: (1) the Children’s Hospital of
Philadelphia (CHOP); (2) phase I of the International Multisite
ADHD Genetics Project (IMAGE); (3) phase II of IMAGE
(IMAGE II); and (4) the Pfizer funded study from the University
of California, Los Angeles, Washington University and the
Massachusetts General Hospital (PUWMa; Neale et al., 2010a).
1http://www.broadinstitute.org/mpg/dapple/dapple.php
2http://www.med.unc.edu/pgc/downloads
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The total sample consists of 2960 childhood ADHD cases, as well
as parental and independent controls.
The CHOP data contains trio families that were recruited
from both pediatric and behavioral health clinics in the
surrounding Philadelphia area (Elia et al., 2009). Patients were
diagnosed based on the K-SADS interview (Kaufman et al., 1997).
Trios were included if the families were of European descent
and contained a proband with ADHD between the ages of 6 and
18 years.
The IMAGE sample also contained trio families that were
collected using a standardized protocol for the collection sites.
These sites included countries in Europe: Belgium, Germany,
Ireland, Netherlands, Spain, Switzerland, United Kingdom, as
well as Israel. At these sites, parents of the affected children were
interviewed using the Parent Account of Childhood Symptom
(PACS), which is a semi-structured diagnostic interview used
to obtain the clinical phenotypes often associated with ADHD
(Chen and Taylor, 2006). Additionally, the parents and the
teachers completed separate versions of the Conners ADHD
rating scales and the Strengths and Difficulties Questionnaire
(Goodman, 1997; Conners et al., 1998). Families diagnosed with
ADHD were retained for the study sample.
The IMAGE II sample contained some of the samples from
the original IMAGE project and combined these with additional
samples provided by other sites (Mick et al., 2010). Similar
methods to the original IMAGE project were used. The rest of
the samples came from several different sites.
One of the sites was located in Germany and thus the families
were of German, Caucasian descent. All of the cases met the
DSM-IV criteria for an ADHD diagnosis. The affected proband
was at least 6 years old, and affected siblings were included if
they were at least 6 years of age as well. All of the children
were accessed using the Present and Lifetime Version of K-SADS
(K-SADS-PL; Kaufman et al., 1997). Parents and teachers also
used the DMS-IV based rating scale to confirm the occurrence
of symptoms.
Another site in Cardiff contained a sample of children, ages
6–16 years, of British, Caucasian ancestry. Their parents were
interviewed using the Parent Child and Adolescent Psychiatric
Assessment (CAPA; Angold and Costello, 2000). Additionally, a
telephone interview with their teacher was conducted using the
Child ADHD Teacher Telephone Interview (CHATTI; Holmes
et al., 2003).
The Scottish site included children, ages 6–16 years, of British,
Caucasian descent. Patients were accessed through the CAPA as
well as the Conners Teacher Rating Scale (Conners et al., 1998;
Angold and Costello, 2000).
At the Dutch Site, participants aged 3–18 years were
diagnosed with ADHD, oppositional defiant disorder (ODD),
conduct disorder (CD), as well as mood and anxiety disorders.
A majority of this data was collected for a sibling pair
genome-wide linkage study of ADHD. Patients were accessed
using the DSM-IV version of the Diagnostic Interview Schedule
for Children (DISC-P; Shaffer et al., 2000). The DISC-P was
supplemented with Conner’s Questionnaire, the Childhood
Behavior Checklist (CBCL), the Teacher Report Form (TRF), and
the Strengths and Weaknesses of ADHD Symptoms and Normal
Behaviors (SWAN; Geller et al., 1996, 2002; Goodman, 1997;
Conners et al., 1998).
The IMAGE II controls consisted of 2653 individuals of
European descent. These controls were initially collected for
a GWAS of schizophrenia (O’Donovan et al., 2008). The
participants were drawn from a US representative survey panel
of 60,000 individuals. Participants were screened for psychosis as
well as bipolar disorder, but not ADHD.
The PUWMa samples contained information from MGH,
Washington University, and UCLA. Three-hundred and nine
families were recruited at the MGH clinics. Only the adult
subjects who had a lifetime DSM-IV-TR diagnosis of ADHD
were enrolled. These enrolled participants were screened using
the DSM-IV-TR and Epidemiologic version of the Schedule for
Affective Disorders and Schizophrenia (K-SADSE; Ambrosini,
2000).
At the Washington University location, 272 families were
selected for a genetic epidemiology study to examine the
prevalence as well as heritability of ADHD. The original sample
contained812male and female twinpairs and six individual twins,
aged 7–19 years, identified from the Missouri Family Registry.
The families were invited to participate if at least one of the twins
experienced at least three inattentive symptoms reported during
a screening interview. The Missouri Assessment of Genetics
Interview for Children (MAGIC) was used to access both the
children and parents (Todd et al., 2003). The DSM-IV ADHD
diagnoses were based on parents’ reports about their children.
At the UCLA site, 156 participants were chosen from
540 individuals, aged 5–18 years, and their parents, originally
from a sample of 370 families that contained ADHD affected
sibling pairs. The children and adolescents were assessed using
the K-SADS-PL (Kaufman et al., 1997). The parents were
assessed using the Lifetime version of SADS (SADS-LA-IV),
as well as the K-SADS Behavioral Disorders module (Kaufman
et al., 1997). The Swanson, Nolan, and Pelham, version IV
(SNAP-IV) rating scale was used as a direct interview method, as
well as the CBCL and TRF (Geller et al., 1996, 2002; Bussing et al.,
2008). In addition, parents rated themselves and their spouses’
behaviors using the ADHD Rating Scale IV (Zhang et al., 2005).
Pre-Imputation Quality Control
Quality control (QC) measures were previously completed
in-house for a cross-disorder genome-wide study that used the
same OCD dataset. QC was conducted using PLINK3 (Purcell
et al., 2007). SNPs with <95% call rate or SNPs with <0.01 allele
frequency were removed. SNPs with a p-value <1 × 10−6 for
the Hardy Weinberg Equilibrium (HWE) test were removed as
well. After QC, 591,322 SNPs remained from the 2998 individuals
for statistical analyses. For the GENEVA controls after QC,
849,063 SNPs were left from the 1296 individuals.
OCD Data Imputation
Imputation was also previously completed for the same cross-
disorder genome-wide study. The IMPUTE24 software was used
3http://zzz.bwh.harvard.edu//plink/
4https://mathgen.stats.ox.ac.uk/impute/impute_v2.html
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(version 2.1.2) as well as 1000 Genomes (June 2014 Data Release)
as a reference dataset (Howie et al., 2009, 2011).The haplotypes
were phased using SHAPEIT25 (version v2.r644) to produce the
best-guess haplotypes (Delaneau et al., 2012).
Post Imputation Quality Control (QC)
Post imputation QC was previously completed for a cross-
disorder genome-wide study on the OCD dataset. GTOOL6
(version v0.7.5) was used to convert the genotype data in
the GEN format to the PLINK PED format. The GEN data
is listed as a set of three probabilities that correspond to
the allele pairs AA, AB and BB. If the largest probability
of the three is over the threshold (0.9), then the genotype
from the PED file was written as the corresponding allele
pair. After QC, the OCD dataset was left with 6,995,151 SNPs
from 2998 individuals. The GENEVA controls contained
6,995,151 SNPs from 1296 unrelated individuals.
The ADHD sample was cleaned prior to upload to the site7.
Therefore, the ADHD sample did not need to undergo additional
QC measures.
Statistical Analysis
Because the OCD dataset has pedigree structure, the initial
genome wide association analyses were completed using FBAT8
(version v2.0.4) for the OCD dataset (Laird et al., 2000). For the
meta-analysis, METAL9 was used to conduct the analysis (Willer
et al., 2010).
Polygenic Risk Score Analyses
PRS analyses were conducted using PRSice10 (version v1.23;
Euesden et al., 2014). The PRS summarizes the genetic effects
of a group of markers (SNPs) that individually do not reach
significance in a large association study (Dudbridge, 2013).
The risk score was calculated as a sum of single-nucleotide
polymorphism alleles that are associated with a specific trait for
an individual (Howie et al., 2009). The score was weighted by
effect sizes that are estimated from a GWAS. In order to examine
the genetic relationship between ADHD and OCD, PRS’s were
calculated.
For this study, ADHD was used as the discovery sample
because that sample size was larger and only the summary
statistics were available for this analysis. Using OCD as the
target dataset and ADHD as the discovery sample, the PRSice
software was used to calculate these scores. PRSice was designed
to automate the steps of the PRS analyses by using both PLINK
(Purcell et al., 2007) and R (R Core Team, 2015). Linkage
disequilibrium (LD) pruning was completed, using p-value
thresholds of p < 0.01, 0.1, 0.2, 0.3, 0.4 and 0.5. PRSice also
automates the LD pruning process. Within each of these LD
thresholds, p-value significance thresholds were determined, and
5https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/shapeit.html
6http://www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html
7https://www.med.unc.edu/pgc/results-and-downloads
8http://www.hsph.harvard.edu/fbat/fbat.htm
9http://csg.sph.umich.edu/abecasis/Metal/
10http://prsice.info/
R2 values were calculated based on how well the regression fits
the data, which can be seen in Figure 1. For each of these
p-value significance thresholds quantitative polygenic scores
were calculated for each individual within the target data. These
scores were calculated by multiplying the number of risk alleles
for each SNP (0, 1, or 2) by the score for that same SNP, estimated
from the discovery sample.
Protein-Protein Link Evaluation
DAPPLE was used to conduct a protein-protein analysis to
examine the connectivity between potential associated proteins
(Rossin et al., 2011). DAPPLE seeks to find significant
physical connectivity between proteins that are encoded by
the genes found in the loci associated with the disease. These
protein-protein interactions are based on reported biological
information between proteins in InWeb, a database of 169,810
high-confidence pairwise interactions involving 12,793 proteins
(Rossin et al., 2011). To test for the non-randomness of these
protein connections, DAPPLE was used to create random
protein interaction networks with a within-degree node-label
permutation method. Random networks hold the same size,
number of edges and number of proteins with the same number
of connections as the original network. Protein names in the
random networks, however, are randomly reassigned to proteins
of equal protein connectivity, allowing for the evaluation of
non-randomness in the original network based on protein
binding degree (Rossin et al., 2011).
Expression Quantitative Trait Locus (eQTL) Analysis
A p-value threshold of p < 1.00 × 10−4 was used in
order to examine the relationship between the candidate
FIGURE 1 | Quantile-quantile (QQ) plot for p-values of the
meta-analysis. QQ plots compare the observed vs. expected test-statistic
distributions. The shading indicates the 95% confidence intervals. The inflation
factor, λ is 1.008.
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SNPs and relevant eQTLs, using the eEQLAnalysis11 software.
eEQLAnalysis can be used to conduct an eQTL analysis
for the selected SNP list based on the Brain Cloud12
data set (GSE30272). This dataset contains both SNP data
and gene expression data from 268 healthy subjects. The
software includes three modules: eQTL Map Generation;
Permutation for Selected eQTLs; and report generation. The
input of the software provides a list of nominated SNPs. The
outputs include the ‘‘significant SNPs’’ and associated statistics
including eQTL p-values and permutation based p-values.
For more information about the software, please refer to:
http://hongbaocao.gousinfo.com/Software4Download.html. The
eQTL analysis we conducted seeks to link SNPs to regions of the
prefrontal cortex.
RESULTS
Meta-Analysis
The final combined dataset consisted of 2998 OCD samples
and 5415 ADHD samples. A total of 6,598,140 SNPs were
analyzed in the meta-analysis. Both the quantile-quantile (QQ)
plot and Manhattan plot show the association p-values from the
meta-analysis (Figures 1, 2, respectively). The QQ plot estimates
if two datasets come from populations that share a common
distribution (Figure 1). It compares the observed vs. expected
distributions of the test statistics. The genomic control inflation
factor, λ in this analysis is 1.008, which provides no evidence for
residual population stratification. The corresponding p-values
from the meta-analysis of both the genotyped and imputed SNPs
are shown in the Manhattan plot (Figure 2). None of the SNPs
reached genome wide significance. A list of the top SNPs can be
found in Table 1. The most significant SNP was rs10989904 with
a p-value of 1.65 × 10−4. This SNP occurs in an intergenic
region.
11http://hongbaocao.gousinfo.com/Software4Download.html
12http://braincloud.jhmi.edu/
FIGURE 2 | Manhattan plot of all the genotyped and imputed SNPs for
p-values of the meta-analysis between the attention deficit
hyperactivity disorder (ADHD) and obsessive compulsive disorder
(OCD) studies.
Polygenic Risk Score Analyses
The polygenic risk model was tested on the target sample to
obtain the PRS for each individual. Logistic regression was
conducted to examine the relationship between risk score and
the case-control status of the target data. The percentage of the
phenotypic variance that can be explained by the risk score was
automated by PRSice (Figure 3).
The R2 value indicates how well the logistic regression
approximates the data, based on the p-value thresholds. The
p-value threshold of 0.15 had an R2 value of 0.0834%. This means
that approximately 0.08% of the data overlapped between the
OCD and ADHD data.
Protein-Protein Link Analysis
SNPs with a p-value <0.001 were included in the analysis to
investigate whether any protein(s) associated with the disorders
would give a statistically significant p-value; A total of 123 genes
were included in the analysis based on this criterion. Six
direct protein-protein interactions were identified and included
ten proteins in all (CHMP4B, EIF2S2, EIF3I, FGF10, FGFR2,
ITCH, PIK3C2B, SELE, SELL and UQCC; Figure 4). The direct
connections are also shown in Table 2. The overall direct
connections protein interaction network had a p-value of 0.0879
(Figure 4). Additionally, 543 indirect connections contributed
to the network that linked the six direct protein interactions.
None of the indirect connectors were of known biological
relevance based on our current understanding of the diseases.
A similar DAPPPLE analysis was conducted previously on an
ADHD sample that found no direct connections (Zayats et al.,
2015).
Exploring Polygenic Risk for ADHD and
OCD
A cross-disorder PRS analysis was completed using the ADHD
data as the discovery sample and the OCD data and GENEVA
controls as the target sample. An LD pruning threshold was
set at 0.1. The predetermined significance thresholds were
p < 0.05, 0.1, 0.15, 0.2, 0.3, 0.4 and 0.5. The corresponding
numbers of SNPs for each threshold were as follows: 11,867
(4.3%), 20,929 (7.7%), 28,664 (10.5%), 35,776 (13.1%), 48,191
(17.7%), 59,096 (21.7%) and 68,295 (25.0%). The 20,929 SNPs
for p< 0.1 in the discovery sample, contributed 0.023% variance
in the target sample. The low variance could be related to the
small number of SNPs included in the analysis. 28,664 SNPs
for p < 0.15 in the discovery sample, contributed 0.083% of
the variance explained by OCD. The other groups of SNPs
contributed between 0.028%–0.079% of the variance explained
by OCD.
Expression Quantitative Trait Locus (eQTL)
Analysis
SNPs with a p-value <1.00 × 10−4 from the genome wide
association tests were included in an eQTL analysis. An eQTL
analysis was conducted in order to compare the results with the
proteins identified from DAPPLE. The top SNPs associated with
the prefrontal cortex are listed in Table 3.
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TABLE 1 | Top SNPs from the meta-analysis.
Chr SNP Position A1/A2 Gene name P-value Direction
9 rs10989904 104030215 T/G 1.65E-04 −−
14 rs234601 96146269 T/C 2.12E-04 −−
17 rs11656215 17393792 T/C PEMT 4.25E-04 −−
1 rs708723 204005889 T/C RAB29, NUCKS1, SLC41A1, SLC45A3 4.52E-04 ++
15 rs7167122 58162157 T/C 5.48E-04 −−
19 rs375323 11247225 T/C DOCK6 6.94E-04 −−
17 rs1901187 35899673 T/C TNS4 8.59E-04 ++
4 rs4557213 177926127 A/G VEGF-C 9.18E-04 ++
17 rs4073996 75056346 T/C 9.33E-04 −−
11 rs2656198 98868897 A/G 1.11E-03 −−
Chr, chromosome; SNP, single nucleotide polymorphism; Position, chromosome positions at hg19, A1, reference allele, A2, alternative allele, GeneName, genes including
SNPs, P-value, meta-analysis p-value, Direction, summary of the effect of the direction for each study.
DISCUSSION
Psychiatric disorders, such as ADHD and OCD, are extremely
complex and clinically heterogeneous. However, it has been
reported that ADHD and OCD may share common sub-
phenotypes. For example, Palumbo et al. (1997) suggested
that ADHD, OCD and autism have overlapping etiologies,
and thus are interrelated. Additionally, Anholt et al. (2010)
found that inattention plays a key role in obsessive-compulsive
symptoms and may further link ADHD and OCD. Despite
the clinical overlap between ADHD and OCD, the genetic
overlap found in this study was limited. It is possible
that the heterogeneity of each of the samples diluted the
association signals in the meta-analysis, and masked the genetic
overlap.
FIGURE 3 | PRSice bar plot for linkage disequilibrium (LD) threshold of
0.1. The tallest bar indicates the best fit polygenic risk score (PRS) for the
ADHD PRS predicting OCD.
To summarize our findings, we conducted a meta-analysis
between ADHD and OCD. The SNP rs10989904 had the
strongest association signal (p-value = 1.65 × 10−4). This SNP
is in an intergenic region, but is near the LOC100127962 pseudo
gene. None of the other SNPs were in any known biologically
relevant genes. The GWAS conducted on the ADHD PGC
data found the most significant SNP on the CDH13 gene
(Neale et al., 2010b). This gene was not identified in the
meta-analysis. We then used DAPPLE to identify any network
of proteins associated with the two disorders. This analysis
found that CHMP4B, EIF2S2, EIF3I, FGF10, FGFR2, ITCH,
PIK3C2B, SELE, SELL and UQCC all contributed to disease
susceptibility. EIF2S2 and FGFR2 were found to be associated
with both disorders. Zayats et al. (2015) reported that EIF2S2may
participate in a protein network that is impaired in individuals
with ADHD.
FIGURE 4 | Protein-Protein interaction network built from proteins
from the SNPs from the meta-analysis. The colored circles represent the
proteins and the different colors are associated with different regions. The gray
lines represent the direct connections between the proteins.
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TABLE 2 | Results of the protein-protein link evaluation in Disease Association Protein-Protein Link Evaluator (DAPPLE), direct interactions.
Protein Region Uncorrected p-value Corrected p-value Binding protein/s Function
FGF10 G70 0.00199 0.00199 FGFR2 Fibroblast growth factor 10
FGF10, UQCC,
FGFR2 G75 0.01394 0.01394 CHMP4B Fibroblast growth factor receptor 2
Ubiquinol-Cytochrome C reductase complex
UQCC G13 0.08598 0.08598 FGFR2 Assembly factor 1
EIF3I G81 0.11629 0.11629 EIF2S2 Eukaryotic translation initiation factor 3
SELE G59 0.11629 0.11629 SELL Selectin E
EIF2S2 G58 0.16079 0.16079 EIF3I Eukaryotic translation initiation factor 2
SELL G36 0.15529 0.15529 SELE Selectin L
CHMP4B G94 0.18442 0.18442 FGFR2 Charged multivesicular body protein 4A
PIK3C2B G25 0.16444 0.16444 ITCH Phosphatidylinositol-4-phosphate 3-kinase
ITCH G60 0.24461 0.24461 PIK3C2B Itchy E3 ubiquitin protein ligase
The p-values are the probability that by chance the individual interactions would be connected to the seed proteins as observed in the network (Figure 4).
Another protein found in the direct network, FGFR2, was
reported to be associated with hyperactive behavior in mice
deficient in the protein (Kaga et al., 2006). Schubert et al. (2014)
also found that FGFR2 is involved in generating the excitatory
glutamatergic pyramidal neurons in the medial prefrontal cortex.
The prefrontal cortex has been implicated in the pathophysiology
of several neurodevelopmental disorders, including ADHD and
OCD, and both disorders exhibit impairments in inhibitory
control (Schubert et al., 2014). However, Norman et al. (2016)
found that the two disorders exhibited different underpinnings
for this impairment.
The eQTL results were compared to the findings from the
DAPPLE analysis. Only one gene overlapped between DAPPLE
and eQLAnalysis. The overlapping gene was SELE, which plays
a role in inflammation. Inflammation, especially in the brain,
has been found to be associated with the development of
neuropsychiatric disorders. Specifically, in populations of youth
and adolescents, there were elevated markers for inflammation
among several neuropsychiatric disorders including ADHD and
OCD (Mitchell and Goldstein, 2014).
More interestingly, the WDFY3 gene was found to be
associated with axon guidance in mice, which was previously
reported to be associated with ADHD (Dragich et al., 2016). A
phenotype of ADHD was shown to be correlated with a failure in
axon guidance (Mooney et al., 2016). The WDFY3 gene had an
eQTL p-value of 2.136 × 10−6 and a permuted p-value of 0.0041
(Table 3).
TABLE 3 | Results of the expression quantitative trait locus (eQTL)
analysis in eEQLAnalysis, top genes.
Gene name Chromosome number eQTL Permutation
p-value p-value
LINC00314 21 1.481E-08 0.0039
CXCR2 2 5.934E-08 0.0029
ASB17 1 6.149E-07 0.0088
SELE 1 6.581E-07 0.0000
ACOT7 1 8.591E-07 0.0003
PRPS1L1 7 1.324E-06 0.0004
ZBF580 19 1.431E-06 0.0027
TAS2R41 7 1.663E-06 0.0049
ADAMTS20 12 1.710E-06 0.0027
WDFY3 4 2.136E-06 0.0041
Our study also showed that SNPs with a p-value <0.15 from
the discovery sample contributed 0.083% of the variance
explained by OCD. In general, psychiatric disorders such as OCD
and ADHD are likely to arise from the influence of a large
number of susceptibility genes across the genome, as well as the
proportion of OCDphenotypic variance explained directly by the
targeted SNP’s (Yu et al., 2015).
Notably, our study has a limited sample size for both
the ADHD and OCD samples, and thus are likely to be
underpowered in detecting statistically robust polygenic score
effects and signals in the meta-analysis. In the future, a
larger sample size may provide a more accurate PRS and
better estimate of heritability. Additionally, the samples may
exhibit heterogeneity that each of these diseases are clinically
heterogeneous.
Clinical heterogeneity tends to increase as the number of
data collection sites increases. A study by Anttila et al. (2016)
examined the genetic correlation between neurological and
psychiatric disorders including ADHD and OCD. It should be
noted that the ADHD dataset used in our analysis was a subset of
the data used in the Anttila et al. (2016) analysis. Our results were
consistent with that of Anttila et al. (2016); no significant genetic
correlation was found between the two disorders.
Although the analyses conducted including meta, PRSs,
DAPPLE provide little evidence to suggest that ADHD and OCD
share common genetic etiologies, our eQTL analysis suggested
a potential role for the WDFY3 gene in psychiatric disorders
such as ADHD and/or OCD. We also anticipate that more
genes/pathways will emerge with future studies of larger sample
sizes.
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